Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth - Archive ouverte HAL Access content directly
Journal Articles Journal of Clinical Investigation Year : 2015

Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth

Coralie Hoareau-Aveilla
  • Function : Author
Thibaud Valentin
  • Function : Author
Camille Daugrois
  • Function : Author
Cathy Quelen
  • Function : Author
Géraldine Mitou
  • Function : Author
Samuel Quentin
Jinsong Jia
  • Function : Author
Salvatore Spicuglia
Technologies avancées pour le génôme et la clinique
Pierre Ferrier
  • Function : Author
Centre d'Immunologie de Marseille - Luminy
Monica Ceccon
  • Function : Author
Sylvie Giuriato
  • Function : Author
Carlo Gambacorti-Passerini
  • Function : Author
Pierre Brousset
Centre de Recherches en Cancérologie de Toulouse
Laurence Lamant
  • Function : Author
Fabienne Meggetto

Abstract

no abstract

Domains

Life Sciences [q-bio]

Lionel Spinelli  : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-01614947

Submitted on : Wednesday, October 11, 2017-4:49:19 PM

Last modification on : Friday, February 17, 2023-9:42:27 AM

Consult the full text

Dates and versions

hal-01614947 , version 1 (11-10-2017)

Identifiers

Cite

Coralie Hoareau-Aveilla, Thibaud Valentin, Camille Daugrois, Cathy Quelen, Géraldine Mitou, et al.. Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth. Journal of Clinical Investigation, 2015, 125 (9), pp.3505--3518. ⟨10.1172/JCI78488⟩. ⟨hal-01614947⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

CNRS UNIV-AMU UNIV-UT3 UT3-TOULOUSEINP
55 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More